GeneOne Life Science, Inc.

Amid the ongoing global financial strains and a high interest rate environment, bioventures in South Korea are increasingly opting to raise funds through rights offerings, despite concerns over share

While global pharma firms are rolling out advanced gene and cell therapies, as well as aggressively making R&D investments in the space to grab the leading position in the burgeoning market, South Kor

Ildong Pharmaceutical Co., Ltd. has joined hands with Shionogi & Co. Ltd. to develop in South Korea the Japanese company's oral antiviral candidate for COVID-19, S-217622. Ildong has already receiv

As the COVID-19 vaccination rate continues to climb in South Korea, EyeGene, Inc. , like other vaccine developers, is facing difficulties in progressing recruitment for clinical trials with its own v